鉴定和管理COPD患者的心肺风险:一个多学科的共识和修改的Delphi研究
Chris P Gale1,2,3, John R Hurst4, Nathaniel M Hawkins5
1Department of Cardiology, Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom.
European journal of preventive cardiology
|March 4, 2025
概括
心血管疾病在慢性阻塞性肺病 (COPD) 中很常见,但往往诊断不足和治疗不足. 评估和管理COPD患者的心肺风险对于更好的结果至关重要.
科学领域:
- 肺部病理学 肺部病理学
- 心脏病学 心脏病学
- 公共卫生 公共卫生
背景情况:
- 心血管疾病 (CVD) 经常与慢性阻塞性肺病 (COPD) 一起发生.
- 在COPD患者中,心血管疾病和相关风险往往被诊断不足,治疗不足.
- 这种诊断不足和治疗不足增加了心肺事件的风险.
研究的目的:
- 制定关于确定和管理COPD患者心肺风险的共识声明.
- 为医疗保健专业人员提供关于COPD背景下评估和管理心血管风险的指导.
- 通过解决尚未满足的公共卫生需求来改善心肺健康结果.
主要方法:
- 一个由COPD和心血管疾病专家组成的全球工作组召开.
- 通过虚拟会议和远程协作,起草和完善了一份共识声明.
- 修改后的Delphi方法被用来完成共识声明和关键建议.
主要成果:
- 一份共识声明强调了评估和管理COPD心肺风险的重要性.
- 患有COPD风险因素或疾病的患者应接受螺旋测量以确认COPD.
- 在COPD中,应遵循临床指导方针来管理流行和发病的心血管疾病 (心力衰竭,血脂不良,高血压,缺血性心脏病,心房动).
- 降低COPD恶化风险对于减轻心肺风险至关重要.
- 建议加强心脏病学,肺病学和初级保健专家之间的合作.
结论:
- 识别和管理COPD心肺风险是一个至关重要的未满足的公共卫生需求.
- 跨学科的合作和共同的理解对于改善COPD患者的心肺结果至关重要.
相关概念视频
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:30Chronic Obstructive Pulmonary Disease-V: Nursing Management
3.5K
Nursing management of Chronic Obstructive Pulmonary Disease (COPD) is crucial for providing thorough care and support to patients. Nurses play an integral role in this process through detailed assessment, careful planning, targeted interventions, and ongoing evaluation. Here's an overview of the critical steps in nursing management for COPD.
Assessment
Assessment
3.5K
01:27Chronic Obstructive Pulmonary Disease-IV: Assessement and Diagnostic Studies
2.5K
Assessing and diagnosing Chronic Obstructive Pulmonary Disease (COPD) involves a detailed approach that includes a comprehensive review of medical history, physical examination, and a variety of diagnostic tests. This thorough evaluation is essential to ensure an accurate diagnosis and guide effective management strategies.
Medical History
Medical History
2.5K
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.7K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.7K
01:26COPD: Management Using Bronchodilators and Corticosteroids
170
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
170
01:25Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.
2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K